Plaintiffs And Japanese Government Agree To Settle Hepatitis Lawsuits
This article was originally published in PharmAsia News
A Sapporo district court has ruled in favor of Japanese hepatitis plaintiffs and has ordered the government to pay ¥36 million for patients who later died or developed severe cirrhosis, ¥25 million for people who suffered mild cirrhosis, ¥12.5 million for chronic hepatitis and ¥50,000 for non-symptom carriers
You may also be interested in...
The pharma giants are joining forces to help the UK reach its ambitious target of testing 100,000 people a day for coronavirus by the end of April.
Angelini is looking to take its recently-acquired ThermaCare brand to the next level by establishing a direct base in Germany to market the product and through a new distribution deal with Norway's Navamedic.
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.